EnsoData

EnsoData

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.ensodata.com

Last Round

Series B

Jun 25, 2025

Total Funding Raised

$51.05M

Momentum Score

25 /100

Company Overview

EnsoData is a healthcare technology company that provides an AI-powered software platform to automate the analysis of sleep studies for clinicians.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS, Telemedicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AI sleep scoringsleep study analysissleep apnea diagnosisFDA-cleared AIsleep techmedical AIwaveform AIremote physiological monitoringRPMpolysomnography analysishome sleep apnea testsleep clinic softwareusage-based billingpulse oximetry analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnsoData Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EnsoData Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJun 25, 2025
Series A ExtensionJun 3, 2022
Series AJun 10, 2020
SeedMar 2, 2018
SeedApr 13, 2016

Key People

Founding team and executive leadership

Nick Glattard

Co-founder CTO

Founding Team

Justin Mortara

President & CEO Investor

Executive Team

Matt Dobereiner

Chief Financial Officer

Executive Team

EnsoData Investors

Notable investors and investment history

InvestorRounds
M25Series B, Seed
HealthX VenturesSeries A Extension, Series A, Seed
Colle CapitalSeries A Extension, Series A, Seed
Dreamit VenturesSeries A
Zetta Venture PartnersSeries A Extension, Series B, Series A
Questa CapitalSeries B
Necessary VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    EnsoHST product cleared for AI-powered sleep diagnosis.

  • Mar 1, 2026

    EnsoSleep product receives FDA clearance for scoring and study management.

EnsoData Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnsoData Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnsoData's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range84
Year Founded2015
Last FundingJun 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.